In another modification of the policy, the MoP has directed that torrefied biomass pellets shall only be procured by utilities for which it is technically unavoidable. This change in the policy has been done because production of torrefied biomass pellets is currently limited in the country compared to its demand.
In an interview with CNBC-TV18, Mark Saldanha, Chairman of Marksans Pharma said the acquisition with Time Cap Laboratories will help in improving company's profitability and will help it entering the US market.